Keiichiro Yoshioka
Chiba, 2608670, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Differential Transcriptomic Features of Peripheral Blood Mononuclear Cells in Pulmonary Sarcoidosis with and Without Extrapulmonary Lesions in an East Asian Population.
Journal: Biomedicines
Published: October 27, 2025
Effects of Anti-Fibrotic Drugs on Transcriptome of Peripheral Blood Mononuclear Cells in Idiopathic Pulmonary Fibrosis.
Journal: International journal of molecular sciences
Published: February 28, 2024
Different Transcriptome Features of Peripheral Blood Mononuclear Cells in Non-Emphysematous Chronic Obstructive Pulmonary Disease.
Journal: International journal of molecular sciences
Published: November 16, 2023
Transcriptome Analysis of Peripheral Blood Mononuclear Cells in Pulmonary Sarcoidosis.
Journal: Frontiers in medicine
Published: November 25, 2021
Clinical Characteristics and Risk Factors of Lung Injury Induced by Nab-Paclitaxel.
Journal: Drug design, development and therapy
Published: November 12, 2021
Exacerbation of autoimmune pulmonary alveolar proteinosis that improved with lone treatment of complicating nontuberculous mycobacterial infection: A case report.
Journal: Respiratory medicine case reports
Published: June 13, 2021
Prognostic value of lymphocyte counts in bronchoalveolar lavage fluid in patients with acute respiratory failure: a retrospective cohort study.
Journal: Journal of intensive care
Published: November 15, 2020
Risk factors for acute exacerbation following bronchoalveolar lavage in patients with suspected idiopathic pulmonary fibrosis: A retrospective cohort study.
Journal: Advances in respiratory medicine
Published: November 14, 2020
What are the factors affecting the recovery rate of bronchoalveolar lavage fluid?
Journal: The clinical respiratory journal
Published: November 02, 2020
The Gender-Age-Physiology system as a prognostic model in patients with idiopathic pulmonary fibrosis treated with nintedanib: a longitudinal cohort study.
Journal: Advances in respiratory medicine
Published: February 13, 2020
Clinical characteristics and risk factors of drug-induced lung injury by ALK tyrosine kinase inhibitors: A single center retrospective analysis.
Journal: Thoracic cancer
Published: December 23, 2019
Last Updated: 09/26/2026